PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » CME

Psychiatric Times. Vol. 29 No. 9
Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  
Previous Next
MINE YOUR MIND 

Alcohol Disorders: Practical Tips From New Research

By Mark J. Niciu Jr, MD, PhD and Ismene Petrakis, MD | September 7, 2012
Dr Niciu is Clinical Research Fellow at the NIMH in Bethesda, Md; Dr Petrakis is Professor of Psychiatry at the Yale School of Medicine, New Haven, Conn, and Chief of Psychiatry at the VA Connecticut Healthcare System in West Haven, Conn. The authors report no conflicts of interest concerning the subject matter of this article.

3. Which of the following is a benzodiazepine that is conjugated and renally cleared and therefore safer to use in patients with hepatic disease?

A. Lorazepam

B. Clonazepam

C. Diazepam

D. Phenazepam

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  
Previous Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.







CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy